Oman veterinary neurodegenerative disease diagnostics market report Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025–2030

Oman Veterinary Neurodegenerative Disease Diagnostics Market is USD 15 Mn, with growth from imaging tech and pet owner awareness for animal welfare.

Region:Middle East

Author(s):Rebecca

Product Code:KRAC3277

Pages:89

Published On:October 2025

About the Report

Base Year 2024

Oman Veterinary Neurodegenerative Disease Diagnostics Market Overview

  • The Oman Veterinary Neurodegenerative Disease Diagnostics Market is valued at USD 15 million, based on a five-year historical analysis. This valuation aligns with the broader Oman animal health and veterinary services market, which is estimated at around USD 150 million, with diagnostics representing a specialized and high-growth niche within the sector. Growth is primarily driven by the increasing prevalence of neurodegenerative diseases in companion animals, advancements in diagnostic imaging and molecular testing, and heightened awareness among pet owners about early disease detection and animal welfare .
  • Muscat and Salalah remain the dominant cities in this market, attributed to their well-established veterinary infrastructure, higher rates of pet ownership, and concentration of advanced veterinary clinics and hospitals. These urban centers are focal points for veterinary innovation and service delivery, further supporting the expansion of diagnostic services for neurodegenerative diseases .
  • The Ministerial Decision No. 107/2023 issued by the Ministry of Agriculture, Fisheries and Water Resources (MAFWR) mandates that all licensed veterinary clinics in Oman must maintain access to advanced diagnostic tools, including imaging and laboratory equipment, for the detection of neurodegenerative and other complex animal diseases. The regulation outlines minimum equipment standards, periodic compliance audits, and reporting requirements to ensure the quality and timeliness of veterinary care .
Oman Veterinary Neurodegenerative Disease Diagnostics Market Size

Oman Veterinary Neurodegenerative Disease Diagnostics Market Segmentation

By Diagnostic Type:The diagnostic type segment encompasses a range of methods used to identify neurodegenerative diseases in animals. Subsegments include Imaging Techniques (MRI, CT scans), Blood Tests, Genetic Testing, Neurological Assessments, Biopsy Procedures, and Others (such as biomarker assays). Imaging techniques are the leading subsegment, favored for their non-invasive approach and high diagnostic accuracy in conditions like canine cognitive dysfunction and feline neurodegenerative disorders .

Oman Veterinary Neurodegenerative Disease Diagnostics Market segmentation by Diagnostic Type.

By End-User:This segment categorizes the market based on the end-users of diagnostic services. Subsegments include Veterinary Clinics, Animal Hospitals, Research Institutions, Pet Owners, and Others (such as veterinary schools). Veterinary Clinics are the dominant end-user segment, reflecting the growing number of pet owners seeking specialized diagnostics and the central role of clinics in the animal healthcare ecosystem .

Oman Veterinary Neurodegenerative Disease Diagnostics Market segmentation by End-User.

Oman Veterinary Neurodegenerative Disease Diagnostics Market Competitive Landscape

The Oman Veterinary Neurodegenerative Disease Diagnostics Market is characterized by a dynamic mix of regional and international players. Leading participants such as IDEXX Laboratories, Inc., Zoetis Inc., Neogen Corporation, Virbac S.A., Vetoquinol S.A., Heska Corporation, Abaxis, Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Elanco Animal Health Incorporated, Cegelec, IDEXX BioAnalytics, Neogen Animal Safety, and VetScan contribute to innovation, geographic expansion, and service delivery in this space.

IDEXX Laboratories, Inc.

1983

Westbrook, Maine, USA

Zoetis Inc.

1952

Parsippany, New Jersey, USA

Neogen Corporation

1982

Lansing, Michigan, USA

Virbac S.A.

1968

Carros, France

Vetoquinol S.A.

1933

Lure, France

Company

Establishment Year

Headquarters

Group Size (Large, Medium, or Small as per industry convention)

Revenue Growth Rate

Market Penetration Rate

Customer Retention Rate

Pricing Strategy

Product Diversification Index

Oman Veterinary Neurodegenerative Disease Diagnostics Market Industry Analysis

Growth Drivers

  • Increasing Prevalence of Neurodegenerative Diseases in Pets:The rise in neurodegenerative diseases among pets, such as canine cognitive dysfunction, has been alarming, with estimates indicating that approximately 15% of dogs over the age of 8 are affected. This growing prevalence is driving demand for specialized diagnostic services. The total number of pet dogs in Oman is around 1.3 million, suggesting a significant market for neurodegenerative diagnostics as pet owners seek effective solutions for their aging companions.
  • Advancements in Diagnostic Technologies:The veterinary diagnostics sector is witnessing rapid technological advancements, particularly in imaging and biomarker identification. For instance, MRI technology has improved diagnostic accuracy by over 35% in identifying neurodegenerative conditions. In Oman, the adoption of these advanced technologies is expected to increase, with investments in veterinary diagnostic equipment projected to reach OMR 6 million in future, enhancing the capabilities of veterinary clinics and hospitals.
  • Growing Awareness Among Pet Owners:Pet owners in Oman are becoming increasingly aware of neurodegenerative diseases and their implications. Educational campaigns and veterinary outreach programs have led to a 30% increase in consultations regarding pet neurological health. This heightened awareness is fostering a proactive approach to pet healthcare, with owners willing to invest in diagnostic services, thereby expanding the market for neurodegenerative disease diagnostics significantly.

Market Challenges

  • High Cost of Advanced Diagnostic Tools:The cost of advanced diagnostic tools, such as MRI and CT scanners, can exceed OMR 120,000, making them financially inaccessible for many veterinary practices in Oman. This high initial investment limits the number of clinics that can offer specialized neurodegenerative diagnostics, thereby constraining market growth. Additionally, ongoing maintenance and operational costs further exacerbate this challenge, hindering widespread adoption.
  • Limited Availability of Trained Veterinary Professionals:There is a notable shortage of trained veterinary professionals specializing in neurology in Oman, with only 20 certified veterinary neurologists available for a pet population of over 1.3 million. This scarcity limits the capacity to diagnose and treat neurodegenerative diseases effectively. The lack of specialized training programs in the region further complicates efforts to build a skilled workforce, posing a significant challenge to market expansion.

Oman Veterinary Neurodegenerative Disease Diagnostics Market Future Outlook

The future of the Oman veterinary neurodegenerative disease diagnostics market appears promising, driven by increasing pet ownership and a shift towards preventive healthcare. As pet owners prioritize health and wellness, the demand for advanced diagnostic services is expected to rise. Furthermore, the integration of telemedicine in veterinary care is likely to enhance access to specialized diagnostics, allowing for timely interventions and improved outcomes for pets suffering from neurodegenerative conditions.

Market Opportunities

  • Expansion of Veterinary Clinics and Hospitals:The establishment of new veterinary clinics and hospitals in Oman is projected to increase by 25% in future. This expansion will create more opportunities for offering specialized neurodegenerative diagnostics, catering to the growing demand from pet owners seeking advanced healthcare solutions for their pets.
  • Development of Telemedicine for Veterinary Diagnostics:The rise of telemedicine in veterinary care presents a unique opportunity to enhance diagnostic services. With an estimated 40% of pet owners expressing interest in remote consultations, the integration of telemedicine can facilitate access to specialized diagnostics, particularly in rural areas, thereby broadening the market reach and improving pet health outcomes.

Scope of the Report

SegmentSub-Segments
By Diagnostic Type

Imaging Techniques (MRI, CT scans)

Blood Tests

Genetic Testing

Neurological Assessments

Biopsy Procedures

Others (e.g., biomarker assays)

By End-User

Veterinary Clinics

Animal Hospitals

Research Institutions

Pet Owners

Others (e.g., veterinary schools)

By Application

Diagnosis of Canine Neurodegenerative Diseases

Diagnosis of Feline Neurodegenerative Diseases

Research and Development

Others (e.g., equine diagnostics)

By Distribution Channel

Direct Sales

Online Sales

Veterinary Distributors

Others (e.g., partnerships with veterinary clinics)

By Region

Muscat

Salalah

Sohar

Nizwa

Others

By Price Range

Low Price Range

Mid Price Range

High Price Range

By Service Type

In-House Diagnostics

Outsourced Diagnostics

Mobile Veterinary Services

Others (e.g., telemedicine services)

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Ministry of Agriculture, Fisheries and Water Resources)

Veterinary Diagnostic Laboratories

Animal Health Product Manufacturers

Veterinary Clinics and Hospitals

Animal Welfare Organizations

Pharmaceutical Companies specializing in Veterinary Medicine

Trade Associations related to Animal Health

Players Mentioned in the Report:

IDEXX Laboratories, Inc.

Zoetis Inc.

Neogen Corporation

Virbac S.A.

Vetoquinol S.A.

Heska Corporation

Abaxis, Inc.

QIAGEN N.V.

Thermo Fisher Scientific Inc.

Bio-Rad Laboratories, Inc.

Elanco Animal Health Incorporated

Cegelec

IDEXX BioAnalytics

Neogen Animal Safety

VetScan

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. Oman Veterinary Neurodegenerative Disease Diagnostics Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 Oman Veterinary Neurodegenerative Disease Diagnostics Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. Oman Veterinary Neurodegenerative Disease Diagnostics Market Analysis

3.1 Growth Drivers

3.1.1 Increasing prevalence of neurodegenerative diseases in pets
3.1.2 Advancements in diagnostic technologies
3.1.3 Growing awareness among pet owners
3.1.4 Supportive government initiatives for veterinary health

3.2 Market Challenges

3.2.1 High cost of advanced diagnostic tools
3.2.2 Limited availability of trained veterinary professionals
3.2.3 Regulatory hurdles in product approvals
3.2.4 Competition from alternative diagnostic methods

3.3 Market Opportunities

3.3.1 Expansion of veterinary clinics and hospitals
3.3.2 Increasing investment in veterinary research
3.3.3 Development of telemedicine for veterinary diagnostics
3.3.4 Collaborations with pharmaceutical companies

3.4 Market Trends

3.4.1 Rise in pet ownership and spending on pet health
3.4.2 Integration of AI in diagnostic processes
3.4.3 Shift towards preventive healthcare in pets
3.4.4 Growth of personalized medicine in veterinary care

3.5 Government Regulation

3.5.1 Veterinary product registration requirements
3.5.2 Compliance with international veterinary standards
3.5.3 Regulations on animal testing and welfare
3.5.4 Guidelines for veterinary diagnostic laboratories

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. Oman Veterinary Neurodegenerative Disease Diagnostics Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. Oman Veterinary Neurodegenerative Disease Diagnostics Market Segmentation

8.1 By Diagnostic Type

8.1.1 Imaging Techniques (MRI, CT scans)
8.1.2 Blood Tests
8.1.3 Genetic Testing
8.1.4 Neurological Assessments
8.1.5 Biopsy Procedures
8.1.6 Others (e.g., biomarker assays)

8.2 By End-User

8.2.1 Veterinary Clinics
8.2.2 Animal Hospitals
8.2.3 Research Institutions
8.2.4 Pet Owners
8.2.5 Others (e.g., veterinary schools)

8.3 By Application

8.3.1 Diagnosis of Canine Neurodegenerative Diseases
8.3.2 Diagnosis of Feline Neurodegenerative Diseases
8.3.3 Research and Development
8.3.4 Others (e.g., equine diagnostics)

8.4 By Distribution Channel

8.4.1 Direct Sales
8.4.2 Online Sales
8.4.3 Veterinary Distributors
8.4.4 Others (e.g., partnerships with veterinary clinics)

8.5 By Region

8.5.1 Muscat
8.5.2 Salalah
8.5.3 Sohar
8.5.4 Nizwa
8.5.5 Others

8.6 By Price Range

8.6.1 Low Price Range
8.6.2 Mid Price Range
8.6.3 High Price Range

8.7 By Service Type

8.7.1 In-House Diagnostics
8.7.2 Outsourced Diagnostics
8.7.3 Mobile Veterinary Services
8.7.4 Others (e.g., telemedicine services)

9. Oman Veterinary Neurodegenerative Disease Diagnostics Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Group Size (Large, Medium, or Small as per industry convention)
9.2.3 Revenue Growth Rate
9.2.4 Market Penetration Rate
9.2.5 Customer Retention Rate
9.2.6 Pricing Strategy
9.2.7 Product Diversification Index
9.2.8 Brand Recognition Score
9.2.9 Operational Efficiency Ratio
9.2.10 Customer Satisfaction Index
9.2.11 R&D Investment Ratio
9.2.12 Market Expansion Strategy

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 IDEXX Laboratories, Inc.
9.5.2 Zoetis Inc.
9.5.3 Neogen Corporation
9.5.4 Virbac S.A.
9.5.5 Vetoquinol S.A.
9.5.6 Heska Corporation
9.5.7 Abaxis, Inc.
9.5.8 QIAGEN N.V.
9.5.9 Thermo Fisher Scientific Inc.
9.5.10 Bio-Rad Laboratories, Inc.
9.5.11 Elanco Animal Health Incorporated
9.5.12 Cegelec
9.5.13 IDEXX BioAnalytics
9.5.14 Neogen Animal Safety
9.5.15 VetScan

10. Oman Veterinary Neurodegenerative Disease Diagnostics Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Ministry of Agriculture and Fisheries
10.1.2 Ministry of Health
10.1.3 Ministry of Environment and Climate Affairs

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment in Veterinary Infrastructure
10.2.2 Funding for Research and Development

10.3 Pain Point Analysis by End-User Category

10.3.1 Veterinary Clinics
10.3.2 Animal Hospitals
10.3.3 Pet Owners

10.4 User Readiness for Adoption

10.4.1 Awareness of Diagnostic Options
10.4.2 Training and Support Needs

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Evaluation of Diagnostic Effectiveness
10.5.2 Expansion into New Diagnostic Areas

11. Oman Veterinary Neurodegenerative Disease Diagnostics Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Business Model Framework


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban Retail Strategies

3.2 Rural NGO Tie-ups


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-sales Service


7. Value Proposition

7.1 Sustainability Initiatives

7.2 Integrated Supply Chains


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding Efforts

8.3 Distribution Setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix
9.1.2 Pricing Band
9.1.3 Packaging Considerations

9.2 Export Entry Strategy

9.2.1 Target Countries
9.2.2 Compliance Roadmap

10. Entry Mode Assessment

10.1 Joint Ventures

10.2 Greenfield Investments

10.3 Mergers & Acquisitions

10.4 Distributor Model


11. Capital and Timeline Estimation

11.1 Capital Requirements

11.2 Timelines for Implementation


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-term Sustainability


14. Potential Partner List

14.1 Distributors

14.2 Joint Ventures

14.3 Acquisition Targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Activity Timeline
15.2.2 Milestone Tracking

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of veterinary health reports and publications from Oman’s Ministry of Agriculture and Fisheries
  • Review of academic journals and articles focusing on neurodegenerative diseases in animals
  • Compilation of market data from industry associations and veterinary organizations in Oman

Primary Research

  • Interviews with veterinarians specializing in neurology and animal health
  • Surveys conducted with veterinary clinics and hospitals across Oman
  • Focus group discussions with pet owners and livestock farmers regarding awareness and treatment options

Validation & Triangulation

  • Cross-validation of findings through multiple expert interviews and field surveys
  • Triangulation of data from veterinary practices, academic research, and market reports
  • Sanity checks through feedback from a panel of veterinary experts and market analysts

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of the overall veterinary market size in Oman and its growth trends
  • Segmentation of the market by types of neurodegenerative diseases and diagnostic methods
  • Incorporation of government health initiatives and funding for veterinary research

Bottom-up Modeling

  • Collection of data on diagnostic test volumes from leading veterinary clinics
  • Estimation of pricing models for diagnostic services and products
  • Calculation of market size based on the number of animals affected and treatment frequency

Forecasting & Scenario Analysis

  • Multi-factor regression analysis considering factors such as pet ownership trends and livestock health awareness
  • Scenario planning based on potential regulatory changes and advancements in veterinary diagnostics
  • Development of baseline, optimistic, and pessimistic market projections through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Veterinary Clinics80Veterinarians, Clinic Managers
Pet Owners120Dog and Cat Owners, Livestock Farmers
Animal Health Researchers40Veterinary Researchers, Academic Professors
Diagnostic Laboratories60Lab Technicians, Laboratory Managers
Government Veterinary Officials40Policy Makers, Regulatory Officers

Frequently Asked Questions

What is the current value of the Oman Veterinary Neurodegenerative Disease Diagnostics Market?

The Oman Veterinary Neurodegenerative Disease Diagnostics Market is valued at approximately USD 15 million, reflecting a specialized segment within the broader Oman animal health and veterinary services market, which is estimated at around USD 150 million.

What factors are driving growth in the Oman Veterinary Neurodegenerative Disease Diagnostics Market?

Which cities are the main hubs for veterinary neurodegenerative disease diagnostics in Oman?

What regulations govern veterinary diagnostics in Oman?

Other Regional/Country Reports

KSA veterinary neurodegenerative disease diagnostics market report size, share, growth drivers, trends, opportunities & forecast 2025–2030

Indonesia Veterinary Neurodegenerative Disease Diagnostics Market

Malaysia Veterinary Neurodegenerative Disease Diagnostics Market

APAC Veterinary Neurodegenerative Disease Diagnostics Market

SEA Veterinary Neurodegenerative Disease Diagnostics Market

Vietnam Veterinary Neurodegenerative Disease Diagnostics Market

Other Adjacent Reports

Indonesia Veterinary Imaging Market

Bahrain Veterinary Genetic Testing Market

KSA Veterinary Blood Testing Market

UAE Animal Health Pharmaceuticals Market

South Africa Veterinary Telemedicine Market

Middle East Pet Insurance Market Report Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030

South Korea Veterinary Laboratory Equipment Market

Oman Animal Nutrition Market

Belgium Veterinary Neurology Services Market

Egypt Pet Care Services Market

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022